A detailed history of Lgt Financial Advisors LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Lgt Financial Advisors LLC holds 105 shares of BIO stock, worth $34,705. This represents 0.09% of its overall portfolio holdings.

Number of Shares
105
Previous 192 45.31%
Holding current value
$34,705
Previous $52.4 Million 33.0%
% of portfolio
0.09%
Previous 0.11%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$263.97 - $344.64 $22,965 - $29,983
-87 Reduced 45.31%
105 $35.1 Million
Q2 2024

Aug 05, 2024

SELL
$268.26 - $339.48 $21,460 - $27,158
-80 Reduced 29.41%
192 $52.4 Million
Q1 2024

May 02, 2024

SELL
$304.11 - $351.99 $3,345 - $3,871
-11 Reduced 3.89%
272 $94.1 Million
Q4 2023

Feb 12, 2024

BUY
$269.37 - $365.04 $2,963 - $4,015
11 Added 4.04%
283 $91.4 Million
Q3 2023

Nov 01, 2023

BUY
$350.25 - $422.63 $95,268 - $114,955
272 New
272 $97.5 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.14B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Lgt Financial Advisors LLC Portfolio

Follow Lgt Financial Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lgt Financial Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lgt Financial Advisors LLC with notifications on news.